🇸🇪 Sweden · EU Public Tender
Läkemedel substans natalizumab
🏛️ Region Skåne, Koncernstab inköp och ekonomistyrning · 📍 KRISTIANSTAD
132.5M €
Estimated value
31 October 2025
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Deadline | 31 October 2025 |
| Awarded to | Biogen Sweden AB |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.